ONLINE DATABASE SEARCH - OI-LS-351-MEMO
1. 49067 OI-LS-351; SCIFINDER-OI-6/20/2006
Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates
Park, Heekyung, Song, Eun Ju, Song, Eun Sil, Lee, Eun Yup, Kim, Cheol Min, Jeong, Seok Hoon, Shin, Jeong Hwan, Jeong, Joseph, Kim, Sunjoo, Park, Young Kil, Bai, Gill-Han, and Chang, Chulhun L
Journal of Clinical Microbiology 2006. 44(5): 1619-1624
2. 49068 OI-LS-351; SCIFINDER-OI-6/20/2006
Oxazolidinone derivatives as antimicrobials, and their preparation, pharmaceutical composition and use for treatment of microbial infections
Das, Biswajit, Yadav, Ajay Singh, Ahmed, Shahadat, Gujrati, Arti, Ghosh, Soma, and Rattan, Ashok
PATENT: WO 2006051408 ISSUE DATE: 20060518
APPLICATION: 2005 PP: 59 pp.
ASSIGNEE: (Ranbaxy Laboratories Limited, India
3. 49069 OI-LS-351; PUBMED-OI-6/26/2006
Targets and Tools: Recent Advances in the Development of Anti-HCV Nucleic Acids
Romero-Lopez, C, Sanchez-Luque, FJ, and Berzal-Herranz, A
Infect Disord Drug Targets 2006. 6(2): 121-45
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16789875&dopt=abstract
4. 49070 OI-LS-351; PUBMED-OI-6/26/2006
Antimicrobial activity studies on some piperidine and pyrrolidine substituted halogenobenzene derivatives
Arslan, S, Logoglu, E, and Oktemer, A
J Enzyme Inhib Med Chem 2006. 21(2): 211-4
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16789435&dopt=abstract
5. 49071 OI-LS-351; PUBMED-OI-6/26/2006
Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase
Koch, U and Narjes, F
Infect Disord Drug Targets 2006. 6(1): 31-41
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16787302&dopt=abstract
6. 49072 OI-LS-351; PUBMED-OI-6/26/2006
Synthesis and evaluation of phenoxy acetic acid derivatives as anti-mycobacterial agents
Yar, MS, Siddiqui, AA, and Ali, MA
Bioorg Med Chem Lett 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16784842&dopt=abstract
7. 49073 OI-LS-351; PUBMED-OI-6/26/2006
Synthesis, antibacterial and antitubercular activities of some 7-+AFs-4-(5-amino-+AFs-1,3,4+AF0-thiadiazole-2-sulfonyl)-piperazin-1-yl+AF0- fluoroquinolonic derivatives
Talath, S and Gadad, AK
Eur J Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16781799&dopt=abstract
8. 49074 OI-LS-351; PUBMED-OI-6/26/2006
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
Johnson, JL, Hadad, DJ, Boom, WH, Daley, CL, Peloquin, CA, Eisenach, KD, Jankus, DD, Debanne, SM, Charlebois, ED, Maciel, E, Palaci, M, and Dietze, R
Int J Tuberc Lung Dis 2006. 10(6): 605-12
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16776446&dopt=abstract
9. 49075 OI-LS-351; PUBMED-OI-6/26/2006
In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates
Tato, M, de, la Pedrosa EG, Canton, R, Gomez-Garcia, I, Fortun, J, Martin-Davila, P, Baquero, F, and Gomez-Mampaso, E
Int J Antimicrob Agents 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16774814&dopt=abstract
10. 49076 OI-LS-351; SCIFINDER-OI-6/20/2006
Synthesis and antimycobacterial activities of certain trifluoromethyl-aminoquinoline derivatives
Mital, Alka, Negi, Villendra Singh, and Ramachandran, Uma
ARKIVOC (Gainesville, FL, United States) 2006.(10): 220-227
11. 49077 OI-LS-351; PUBMED-OI-6/26/2006
Characterization of the phosphorylation sites of Mycobacterium tuberculosis serine/threonine protein kinases, PknA, PknD, PknE, and PknH by mass spectrometry
Molle, V, Zanella-Cleon, I, Robin, JP, Mallejac, S, Cozzone, AJ, and Becchi, M
Proteomics 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16739134&dopt=abstract
12. 49078 OI-LS-351; PUBMED-OI-6/26/2006
Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis
Slayden, RA, Knudson, DL, and Belisle, JT
Microbiology 2006. 152(Pt 6): 1789-97
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16735741&dopt=abstract
13. 49079 OI-LS-351; PUBMED-OI-6/26/2006
Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus
Le Pogam, S, Kang, H, Harris, SF, Leveque, V, Giannetti, AM, Ali, S, Jiang, WR, Rajyaguru, S, Tavares, G, Oshiro, C, Hendricks, T, Klumpp, K, Symons, J, Browner, MF, Cammack, N, and Najera, I
J Virol 2006 . 80(12): 6146-6154
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16731953&dopt=abstract
14. 49080 OI-LS-351; WOS-OI-6/26/2006
EmbR, a regulatory protein with ATPase activity, is a substrate of multiple serine/threonine kinases and phosphatase in Mycobacterium tuberculosis
Sharma, K, Gupta, M, Krupa, A, Srinivasan, N, and Singh, Y
FEBS JOURNAL: FEBS J 2006. 273(12): 2711-2721, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237954700012
15. 49081 OI-LS-351; WOS-OI-6/26/2006
Toxoplasma gondii: In vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1 '-propen-3-phenyl)-1, 4-naphthoquinone alone or combined with sulfadiazine
Ferreira, RA, Oliveira, AB, Ribeiro, MFB, Tafuri, WL, and Vitor, RWA
EXPERIMENTAL PARASITOLOGY: Exp. Parasitol 2006. 113(2): 125-129, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237993600008
16. 49082 OI-LS-351; WOS-OI-6/26/2006
Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis I. Modifications to the adenine moiety
Long, MC and Parker, WB
BIOCHEMICAL PHARMACOLOGY: Biochem. Pharmacol 2006. 71(12): 1671-1682, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000238056200002
17. 49083 OI-LS-351; SCIFINDER-OI-6/20/2006
Bisbenzamidines for the treatment of Pneumocystis pneumonia or other infection
Walzer, Peter D, Cushion, Melanie T, Mayence, Annie, Huang, Tien Liang, and Vanden Eynde, Jean Jacques
PATENT: WO 2006021833 ISSUE DATE: 20060302
APPLICATION: 2004 PP: 68 pp.
ASSIGNEE: (University of Cincinnati, USA
18. 49084 OI-LS-351; SCIFINDER-OI-6/20/2006
Nonclassical 5-Alkyl-6-substituted arylthio-pyrrolo[2,3-d]pyrimidines as potent and selective Toxoplasma gondii dihydrofolate reductase inhibitors
Gangjee, Aleem, Jain, Hiteshkumar D, Kisliuk, Roy L, and Queener, Sherry F
Abstracts of Papers, 231st ACS National Meeting, Atlanta, GA, United States, March 26-30, 2006 2006.: MEDI-348
19. 49085 OI-LS-351; SCIFINDER-OI-6/20/2006
The effect of lectins on Cryptosporidium parvum oocyst in vitro attachment to host cells
Stein, Barry, Stover, Larry, Gillem, Ashley, Winters, Katherine, Lee, John H, and Chauret, Christian
Journal of Parasitology 2006. 92(1): 1-9
20. 49086 OI-LS-351; WOS-OI-6/26/2006
NIM811: An HCV replication inhibitor of novel mechanism, exhibits potent antiviral activities alone or in combination with a non-nucleoside HCV polymerase inhibitor
Boerner, JE, Ma, S, Yip, CLT, Cooreman, MP, Compton, T, and Lin, K
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A34-A35, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200024
21. 49087 OI-LS-351; WOS-OI-6/26/2006
R1479 is a highly selective inhibitor of NS5B-dependent HCV replication and does not inhibit human DNA and RNA polymerases
Ma, H, Le Pogam, S, Leveque, V, Li, WX, Jiang, WR, Najera, I, Symons, J, Cammack, N, and Klumpp, K
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A35-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200025
22. 49088 OI-LS-351; WOS-OI-6/26/2006
Design and synthesis of novel anthranilic acid analogs as HCV polymerase inhibitors
Curran, K, Nittoli, T, Insaf, S, Prashad, A, Floyd, B, Orlowski, M, Howe, A, Chropra, R, Agrawal, A, and Bloom, J
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A53-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200073
23. 49089 OI-LS-351; WOS-OI-6/26/2006
Synthesis and evaluation of novel potential HCV helicase inhibitors
Brancale, A, Vlachakis, D, Barbera, MC, Silvestri, R, Berry, C, and Neyts, J
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A53-A54, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200074
24. 49090 OI-LS-351; WOS-OI-6/26/2006
Identification of novel HCV inhibitors utilizing virtual screening
Cameron, DR
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A54-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200075
25. 49091 OI-LS-351; SCIFINDER-OI-6/20/2006
The design of hepatitis C protease inhibitors and the discovery of VX-950
Perni, RB
Abstracts, 37th Great Lakes Regional Meeting of the American Chemical Society 2006. 37: GLRM-028
26. 49092 OI-LS-351; WOS-OI-6/26/2006
HCVNS5B normucleoside inhibitors specifically block synthesis of single-stranded viral RNA catalyzed by HCV replication complexes in vitro
Yang, WG, Sun, YN, Phadke, A, Deshpande, M, and Huang, MJ
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A54-A55, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200077
27. 49093 OI-LS-351; WOS-OI-6/26/2006
Potent inhibition of both HIV and HCV in vitro by a ring-expanded ("fat") nucleoside: Part II. Mechanistic studies of anti-HCV activity
Zhang, N, Zhang, P, Korba, B, Oldach, D, Lagrange, S, Cova, L, Baier, A, Borowski, P, Fattom, A, Winston, S, Fahim, R, and Hosmane, RS
ANTIVIRAL RESEARCH: Antiviral Res 2006. 70(1): A55-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237011200078
28. 49094 OI-LS-351; SCIFINDER-OI-6/20/2006
Preparation of nucleoside analogs for treating Hepatitis C and other Flaviviridae family viral infections
Keicher, Jesse D, Roberts, Christopher D, and Dyatkina, Natalia B
PATENT: US 2006111311 ISSUE DATE: 20060525
APPLICATION: 2005-18840 PP: 23 pp.
ASSIGNEE: (Genelabs Technologies, Inc. USA
29. 49095 OI-LS-351; SCIFINDER-OI-6/20/2006
Inhibition of hepatitis C replicon RNA synthesis by b-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication
Stuyver, Lieven J, McBrayer, Tamara R, Tharnish, Phillip M, Clark, Jeremy, Hollecker, Laurent, Lostia, Stefania, Nachman, Tammy, Grier, Jason, Bennett, Matthew A, Xie, Meng-Yu, Schinazi, Raymond F, Morrey, John D, Julander, Justin L, Furman, Phillip A, and Otto, Michael J
Antiviral Chemistry & Chemotherapy 2006. 17(2): 79-87
30. 49096 OI-LS-351; WOS-OI-6/18/2006
Inhibition of viruses by RNA interference
Stram, Y and Kuzntzova, L
VIRUS GENES 2006. 32(3): 299-306, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237866400009
31. 49097 OI-LS-351; WOS-OI-6/18/2006
The effect of the administration of human gamma globulins in a model of BCG infection in mice
Olivares, N, Leon, A, Lopez, Y, Puig, A, Cadiz, A, Falero, G, Martinez, M, Sarmiento, ME, Farinas, M, Infante, JF, Sierra, G, Solis, RL, and Acosta, A
TUBERCULOSIS 2006. 86(3-4): 268-272, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237868900016
32. 49098 OI-LS-351; SCIFINDER-OI-6/20/2006
Preparation of pyrazoles and [1,2,4]triazoles as antiviral agents
Shipps, Gerald W Jr, Curran, Patrick J, Annis, DAllen, Nash, Huw M, Cooper, Alan B, Zhu, Hugh Y, Wang, James J-S, Desai, Jagdish A, and Girijavallabhan, Viyyoor Moopil
PATENT: WO 2006050034 ISSUE DATE: 20060511
APPLICATION: 2005 PP: 104 pp.
ASSIGNEE: (Schering Corporation, USA
33. 49099 OI-LS-351; SCIFINDER-OI-6/20/2006
Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.bul.4A serine protease
Lin, C, Kwong, AD, and Perni, RB
Infectious Disorders: Drug Targets 2006. 6(1): 3-16
34. 49100 OI-LS-351; SCIFINDER-OI-6/20/2006
Synthesis and antiviral evaluation of alkoxyalkyl esters of phosphonopropoxymethyl-guanine and phosphonopropoxymethyl-diaminopurine
Ruiz, Jacqueline C, Aldern, Kathy A, Beadle, James R, Hartline, Caroll B, Kern, Earl R, and Hostetler, Karl Y
Antiviral Chemistry & Chemotherapy 2006. 17(2): 89-95
35. 49101 OI-LS-351; SCIFINDER-OI-6/20/2006
Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus-associated disease
Zeligs, Michael A
PATENT: WO 2006047716 ISSUE DATE: 20060504
APPLICATION: 2005 PP: 71 pp.
ASSIGNEE: (Bioresponse LLC, USA
36. 49102 OI-LS-351; SCIFINDER-OI-6/20/2006
Preparation of nucleoside-lipid conjugates as antiviral and antitumor agents
Ahmad, Moghis U, Ali, Shoukath M, Khan, Abdul R, and Ahmad, Imran
PATENT: WO 2006029081 ISSUE DATE: 20060316
APPLICATION: 2005 PP: 72 pp.
ASSIGNEE: (Neopharm, Inc. USA
37. 49103 OI-LS-351; WOS-OI-6/18/2006
Biological activity of Tat (47-58) peptide on human pathogenic fungi
Jung, HJ, Park, Y, Hahm, KS, and Lee, DG
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2006. 345(1): 222-228, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237877700032